Jain Global’s Apellis Pharmaceuticals APLS Stock Holding History

Jain Global’s Portfolio APLS Stock Details APLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-27,793	Closed	-$1.12M	–	1728
2026 Q1	$1.12M	Buy	27,793 +10,916	+65%	+$235K	﹤0.01%	786
2025 Q4	$424K	Buy	+16,877	New	+$396K	﹤0.01%	871
2025 Q2	–	Sell	-11,719	Closed	-$256K	–	1175
2025 Q1	$256K	Buy	+11,719	New	+$324K	﹤0.01%	738

Other funds holding APLS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Jain Global's APLS Position: Q2 2026 in Review

Jain Global sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 27,793 shares — an estimated $1.12M sold.

Jain Global first reported a position in APLS in Q1 2025 and held it in 3 quarters. The position peaked at $1.12M in Q1 2026. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

Jain Global reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Jain Global sold 27,793 Apellis Pharmaceuticals shares in Q2 2026, an estimated $1.12M.
Jain Global first reported a position in Apellis Pharmaceuticals in Q1 2025 and held it in 3 quarters.
Jain Global's Apellis Pharmaceuticals position peaked at $1.12M in Q1 2026.
1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on Jain Global's 13F filing for Q2 2026, filed 14 Aug 2026.